申请人:ASTELLAS PHARMA INC.
公开号:US20160002218A1
公开(公告)日:2016-01-07
[Problem]
A compound which is useful as an active ingredient of a pharmaceutical composition for treating storage dysfunctions, voiding dysfunctions, and lower urinary tract diseases is provided.
[Means for Solution]
The present inventors have found that a thiazole derivative having pyrazine-2-carbonylamino substituted at the 2-position is an excellent muscarinic M
3
receptor positive allosteric modulator, and is useful as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M
3
receptor, thereby completing the present invention. The 2-acylaminothiazole derivative or a salt thereof of the present invention can be used as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M
3
receptor, for example, voiding dysfunctions such as underactive bladder.
[问题]提供一种化合物,该化合物可用作治疗储存功能障碍、排尿功能障碍和下尿路疾病的药物组合物的活性成分。[解决方案]本发明人发现,在2位取代吡嗪-2-羧酰胺的噻唑衍生物是一种优秀的肌动蛋白M3受体正向变构调节剂,并且可用作预防和/或治疗与肌动蛋白M3受体引起的膀胱收缩有关的膀胱或尿路疾病的药物,从而完成了本发明。本发明的2-酰胺基噻唑衍生物或其盐可用作预防和/或治疗与肌动蛋白M3受体引起的膀胱收缩有关的膀胱或尿路疾病的药物,例如,排尿功能障碍,如无力膀胱。